Thailand requesting Sinovac to provide more clinical trials data


A medical officer os holding a dose of the Sinovac's vaccine at a district health facility as Indonesia begins mass vaccination for the coronavirus disease, starting with its healthcare workers, in Jakarta, Indonesia, on January 14, 2021. - Reuters

BANGKOK, Jan 15 (Bernama): Thailand, which is expected to receive its first batch of the Covid-19 vaccine from Sinovac Biotech in February, is asking for more information from the Chinese company on its clinical trials before the delivery.

Centre for COVID-19 Situation Administration (CCSA) spokesman, Thaweesilp Wissanuyothin said Thailand’s primary consideration on Covid-19 vaccine was safety and efficacy.

At present, he said, the Thai Food and Drug Administration (FDA) received requests for vaccine registration from AstraZeneca and Sinovac.

"The Thai FDA has already made a request to Sinovac to provide it with more detailed information on the clinical trials,” he said at the Covid-19 daily briefing in the capital.

The effectiveness of Sinovac’s vaccine has triggered concerns following data from a Brazil trial showing that it was only 50.4 per cent effective at preventing symptomatic infections.

Director-general of the Medical Science Department, Supakit Sirilak said Thailand was on track to receive China’s Sinovac vaccine starting next month despite the trial data showing lower efficiency.

Thailand has procured two million doses of Covid-19 vaccine developed by China’s pharmaceutical company, Sinovac Biotech Ltd. The first shipment of 200,000 doses is expected to arrive by the end of February and 800,000 doses by end of March and one million doses by end of April.

Under the National Vaccination Plan, Thaweesilp said the first batch of 200,000 Sinovac’s vaccine will be given to high-risk groups in areas where the transmission rate is high in the latest outbreak, including medical and public health personnel, patients with underlying health conditions, and citizens aged 60 and above.

Thailand has also ordered 61 million doses of the Oxford-AstraZeneca COVID-19 vaccine. Siam Bioscience will be producing Covid-19 vaccine using the formula and technology developed by AstraZeneca Plc, with its first batch to be ready by May. - Bernama
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Thailand , Covid-19 , Vaccine , Sinovac , Clinical Data

   

Did you find this article insightful?

Yes
No

80% readers found this article insightful

Next In Aseanplus News

Asean News Headlines as at 7pm on Sunday (March 7)
Swiss to back Indonesia trade deal and ban on face-veils
China says hopes US will remove 'unreasonable' curbs on cooperation
China says willing to engage with all parties to ease Myanmar situation
China: Zhong Nanshan, Chen Wei embark on new type of vaccine R&D
Indonesia claims success for lowest deforestation rate in 5 years as Covid-19 cases are still rising and goes above 1.379 million
New Covid-19 cases in Philippines breach 3,000-mark for 3rd straight day; 594,412 in total
Thailand mulls Covid-19 vaccine passports to boost tourism sector; 65 Covid-19 cases on Sunday (March 7)
Singapore students still without TraceTogether tokens to receive them by end of March; 13 imported Covid-19 cases on Sunday (March 7)
Covid-19: 1,683 new cases, three deaths bring death toll to 1,169

Stories You'll Enjoy


Vouchers